Skip to main content

Meet Our Team

Our team comprises industry veterans and experts dedicated to providing exceptional CDMO services. With years of experience and a deep understanding of the biotechnology landscape, we are committed to your success.

CEO

Dr. Donald Gerson

  • Produced many vaccines including world’s 1st children’s pneumonia vaccine
  • Technical lead on smallpox vaccine redevelopment after 9/11
  • Managed 50% of US vaccine requirement at Wyeth
  • Founded Celltrion, largest CDMO in Asia (mkt cap $28B)
Chairman

Neal Mody

  • Founder and first CEO of Ambature, high-temperature superconductor company delivering to US Navy
  • Co-founder of HDT Bio, RNA company with >$500M in US government grants/contracts
  • Grew companies to large IP holders with over 5000 claims
  • Serves on board of 10 early-stage health companies
India Executive Chairman

Mayank Trivedi

  • Founder of Sysware Health Systems, grew to multinational company with over 700 employees, exited to Allscripts
  • President & CEO of mobile phlebotomy company myOnsite Healthcare
  • President & CEO of health IT company INDRAlok
  • Global health startup investor
VP of Engineering

Jonas Gerson

  • 10 years experience managing Descartes’s Montreal facility
  • 20 years experience in bioprocessing engineering
  • Senior engineering management of 3 CDMOs
  • MS Chemical Engineering, Queen’s University
VP of Business Affairs

Ian Eliason

  • 10 years experience in business and transaction structure
  • Structured research institute spinout with 26 contracts across 7 US agencies
  • Advisor and investor to 12 early-stage companies
Director of IP

Adrian Berliner

  • Manage IP strategy as health VC partner
  • Expert technologist, co-represented Harvard University at DARPA
  • Partner, Zoic Capital
  • MS Chemical Biology, Harvard University